EPM spoke exclusively with Heiko Schmidt, Strategy & Consulting Life Sciences lead, Accenture AG, about why CDMOs should be prepared to track sustainability metrics now and how companies which wait, will likely be forced to catch-up at higher costs.
Rich Quelch, global head of marketing, Origin looks at the barriers to adoption of sustainable packaging alternatives in pharma and how the industry is working to overcome them.
Despite the carbon footprint from packaging pills to active pharmaceutical ingredient (API) development, Aleiya Lonsdale, head of Event, Lab Innovations, explains how pharma companies in the UK can do their part to help achieve net zero by 2040.
Andrew Toher, head of customer insights at Enel X, discusses the sustainable energy strategies that pharma manufacturers are using to reduce carbon emissions and create valuable sources of new income.
Zeb Ahmed, CEO of BES - the specialist in design and construction of cGMP compliant pharmaceutical facilities, discusses the growing demand for sustainable built assets, why the trend is escalating and what can be done to enhance sustainability.
Gary Connors, partner at Oliver Wight looks at why the pharmaceutical sector is lagging behind other sectors in removing plastic from their products and processes?
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance.
Nusqe Spanton, CEO and founder of Provectus Algae looks at how photosynthesis can offer sustainability in biomanufacturing and the role of microalgae play in this.
Life science manufacturing has notoriously high energy consumption, often due to the necessary use of cleanrooms. However, Cillian Casey, head of Operations and Customer Success – EMEA, at CIM argues that the solution lies in HVAC energy reduction.
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR).
